MX344328B - Abertura de anillo de lactonas y lactamas. - Google Patents

Abertura de anillo de lactonas y lactamas.

Info

Publication number
MX344328B
MX344328B MX2013009618A MX2013009618A MX344328B MX 344328 B MX344328 B MX 344328B MX 2013009618 A MX2013009618 A MX 2013009618A MX 2013009618 A MX2013009618 A MX 2013009618A MX 344328 B MX344328 B MX 344328B
Authority
MX
Mexico
Prior art keywords
ring
present
lactams
lactones
ring opening
Prior art date
Application number
MX2013009618A
Other languages
English (en)
Inventor
Alene Foley Megan
F Jamison Timothy
Repic Oljan
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX344328B publication Critical patent/MX344328B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona un proceso novedoso para abrir un anillo de lactona y/o de lactama. De una manera más particular, la presente invención proporciona un proceso que emplea un catalizador novedoso en la abertura de un anillo de lactona y/o de un anillo de lactama. Adicionalmente, la presente invención también proporciona un proceso de desprotección novedoso de cualquier grupo protector presente ya sea en el compuesto que contiene anillo de lactona y/o que contiene anillo de lactama y/o en el producto de anillo abierto de los mismos.
MX2013009618A 2009-08-11 2010-08-11 Abertura de anillo de lactonas y lactamas. MX344328B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23288609P 2009-08-11 2009-08-11
US23288009P 2009-08-11 2009-08-11
PCT/US2010/045121 WO2011019789A1 (en) 2009-08-11 2010-08-11 The ring opening of lactones and lactams

Publications (1)

Publication Number Publication Date
MX344328B true MX344328B (es) 2016-12-13

Family

ID=42813428

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2012001850A MX2012001850A (es) 2009-08-11 2010-08-11 Abertura de anillo de lactonas y lactamas.
MX2013009618A MX344328B (es) 2009-08-11 2010-08-11 Abertura de anillo de lactonas y lactamas.
MX2013009617A MX347956B (es) 2009-08-11 2010-08-11 Abertura de anillo de lactonas y lactamas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2012001850A MX2012001850A (es) 2009-08-11 2010-08-11 Abertura de anillo de lactonas y lactamas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2013009617A MX347956B (es) 2009-08-11 2010-08-11 Abertura de anillo de lactonas y lactamas.

Country Status (12)

Country Link
US (1) US8779198B2 (es)
EP (1) EP2464623B1 (es)
JP (1) JP5746696B2 (es)
KR (1) KR101755052B1 (es)
CN (1) CN102686556A (es)
AU (1) AU2010282623B2 (es)
BR (1) BR112012003255B1 (es)
CA (1) CA2769186C (es)
IN (1) IN2012DN00862A (es)
MX (3) MX2012001850A (es)
RU (1) RU2550691C2 (es)
WO (1) WO2011019789A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2551260A1 (en) 2011-07-28 2013-01-30 Chemo Ibérica, S.A. Chemical process for opening ring compounds
CN102351734B (zh) * 2011-09-05 2014-02-26 浙江普洛医药科技有限公司 一种阿利克仑的制备方法
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren
CN108940117B (zh) * 2018-08-03 2020-07-24 郑州轻工业学院 一种含羟基联接基团的非离子糖基型双子表面活性剂及其制备方法
CN110452231B (zh) * 2019-08-16 2023-03-28 上海应用技术大学 一种色氨酸类化合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729985A (en) * 1985-08-09 1988-03-08 Pfizer Inc. Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
FI870474A (fi) 1986-02-07 1987-08-08 Ciba Geigy Ag Med svavelhaltiga grupper substituerade 5-amino-4-hydroxivalerylderivat.
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
WO2003103653A1 (en) * 2002-06-11 2003-12-18 Elan Pharmaceuticals, Inc. Methods of treating alzheimer's disease using aryl alkanoic acid amides
BRPI0417017A (pt) 2003-11-26 2007-02-21 Novartis Ag compostos orgánicos
GB0419361D0 (en) * 2004-08-31 2004-10-06 Novartis Ag Organic compounds
GB0511686D0 (en) * 2005-06-08 2005-07-13 Novartis Ag Organic compounds
GB0521083D0 (en) 2005-10-17 2005-11-23 Novartis Ag Organic compounds
GB0605780D0 (en) * 2006-03-22 2006-05-03 Syngenta Ltd Formulations
KR20100016137A (ko) * 2007-04-03 2010-02-12 노파르티스 아게 신규한 방법

Also Published As

Publication number Publication date
MX2012001850A (es) 2012-03-07
WO2011019789A1 (en) 2011-02-17
CA2769186C (en) 2016-10-04
US8779198B2 (en) 2014-07-15
CA2769186A1 (en) 2011-02-17
MX347956B (es) 2017-05-16
RU2012108932A (ru) 2013-09-20
EP2464623A1 (en) 2012-06-20
KR20120054628A (ko) 2012-05-30
US20120165555A1 (en) 2012-06-28
JP2013501797A (ja) 2013-01-17
BR112012003255A8 (pt) 2016-05-17
JP5746696B2 (ja) 2015-07-08
AU2010282623A1 (en) 2012-02-23
IN2012DN00862A (es) 2015-07-10
RU2550691C2 (ru) 2015-05-10
EP2464623B1 (en) 2020-11-04
CN102686556A (zh) 2012-09-19
AU2010282623B2 (en) 2013-12-12
BR112012003255A2 (pt) 2016-03-01
BR112012003255B1 (pt) 2018-10-23
KR101755052B1 (ko) 2017-07-06

Similar Documents

Publication Publication Date Title
UA110199C2 (en) Solid rifaximin dispersion
TW200608973A (en) Rapamycin polymorph Ⅱ and uses thereof
MX2011002966A (es) Formas de dosificacion farmaceutica que comprenden poli (e-caprolactona).
TN2012000147A1 (en) 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
MX344328B (es) Abertura de anillo de lactonas y lactamas.
MY140739A (en) 2, 6-quinolinyl derivatives, processes for preparing them and their uses
MX2011008621A (es) Proceso para la purificacion de lipopeptidos.
IN2012DN05171A (es)
TW200702331A (en) Process for preparing alkylanilides
MY151005A (en) Amide compounds as boosters of antivirals
WO2013080217A3 (en) Crystalline forms of carbazitaxel and process for preparation thereof
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
MX2007010143A (es) Formas cristalinas de intermedio de linezolid.
WO2009137714A3 (en) Forms of lapatinib ditosylate and processes for preparation thereof
GB201303865D0 (en) Pharmaceutical composition and method of inhibiting of production or amplifyingelimination of P24 protein
MX339461B (es) Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso.
WO2010119450A3 (en) An improved process for the preparation of desmopressin or its pharmaceutically acceptable salts
WO2010059916A3 (en) Preparation of docetaxel
PL2091478T3 (pl) Opakowanie prezerwatyw
MX2010003056A (es) Polimorfos de valomaciclovir.
HK1131156A1 (en) Novel morphine derivatives
WO2008138591A3 (en) Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses
MX2009006748A (es) Proceso para la preparacion y aislamiento de los estereoisomeros individuales de fenilciclopentan-carboxilatos 3-sustituidos de 1-amino.
HK1168845A1 (en) Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo[2.2.1]hept-5-enes (1s4r)-2--3-[221]-5-
WO2010131118A3 (en) Polymorphs of etravirine and processes for preparation thereof